Changing the diagnosis of acute myocardial infarction: implications for practice and clinical investigations.
Newby
L Kristin
LK
Duke Clinical Research Institute, Durham, NC 27715-7969, USA. newby001@mc.duke.edu
Alpert
Joseph S
JS
Ohman
E Magnus
EM
Thygesen
Kristian
K
Califf
Robert M
RM
D015906:Angioplasty, Balloon, Coronary; D002986:Clinical Trials as Topic; D003245:Consensus Statements as Topic; D001026:Coronary Artery Bypass; D003402:Creatine Kinase / Q000097:blood*; D052279:Creatine Kinase, MB Form; D005060:Europe; D006291:Health Policy; D006801:Humans; D007527:Isoenzymes / Q000097:blood*; D009203:Myocardial Infarction / Q000097:blood / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy; D009206:Myocardium / Q000473:pathology*; D009336:Necrosis; D011379:Prognosis; D012680:Sensitivity and Specificity; D014336:Troponin / Q000097:blood*; D014481:United States
D007527:Isoenzymes; D014336:Troponin; D003402:Creatine Kinase; D052279:Creatine Kinase, MB Form